dihexa cancer hgf c-met risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Dihexa: Mechanism, Effects & Research

dihexa cancer

dihexa cancer hgf c-met risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Dihexa: Mechanism, Effects & Research

Name: dihexa cancer hgf c-met risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Dihexa: Mechanism, Effects & Research
Brand: www.adamsavageproperty.com.au
SKU: 91318866869
Price: 21.00 USD
Availability: InStock
Rating: 4.8109 (25 reviews)

SKU: 91318866869

4.8

USD21.00 USD43.00

Pay in 4 interest-free payments of $5.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

We go to great lengths to ensure that

Dihexa is not FDA-approved for any indication and has no published human safety data

Early Trials in GI Disorders: The originators of BPC-157 in Europe conducted some early-phase trials in the late 1990s and early 2000s on patients with ulcerative colitis (an inflammatory bowel disease)